NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NEO on Nasdaq
CUSIP
64049M209
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
130M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
129M
Holdings value
$994M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
246
Number of buys
113
Number of sells
-133
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.6% $146M 18.9M BlackRock, Inc. Sep 30, 2025
First Light Asset Management, LLC 7.57% $73.3M 9.78M Mathew P. Arens Jun 30, 2025
Greenhouse Funds LLLP 5.8% $55.7M 7.43M Greenhouse Funds LLLP Jun 30, 2025
MILLENNIUM MANAGEMENT LLC 4.97% $64.9M 6.44M Millennium Management LLC Nov 24, 2025
JANUS HENDERSON GROUP PLC 4.8% $63.3M 6.17M JANUS HENDERSON GROUP PLC Dec 31, 2024
INTEGRATED CORE STRATEGIES (US) LLC 2.8% -52% $26.1M -$24.8M 3.57M -48.7% Millennium Management LLC Jun 30, 2025
T. Rowe Price Investment Management, Inc. 2.6% $34.1M 3.32M T. Rowe Price Investment Management, Inc. Mar 31, 2025

Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 129M $994M +$12.8M $7.72 246
2025 Q2 127M $929M -$11.9M $7.31 269
2025 Q1 126M $1.2B +$20.7M $9.49 248
2024 Q4 123M $2.02B -$12M $16.48 246
2024 Q3 123M $1.82B -$36.3M $14.75 266
2024 Q2 126M $1.74B -$12.5M $13.87 254
2024 Q1 128M $2.01B +$25.2M $15.72 262
2023 Q4 126M $2.03B +$107M $16.18 280
2023 Q3 119M $1.47B +$15.1M $12.30 275
2023 Q2 117M $1.89B +$17.9M $16.07 259
2023 Q1 116M $2.02B +$68.4M $17.41 251
2022 Q4 112M $1.04B +$6.81M $9.24 234
2022 Q3 112M $968M -$61.2M $8.61 236
2022 Q2 117M $956M +$559K $8.15 222
2022 Q1 111M $1.35B -$179M $12.15 263
2021 Q4 118M $4.02B +$22M $34.12 301
2021 Q3 116M $5.58B +$213M $48.24 318
2021 Q2 111M $5.03B +$185M $45.17 309
2021 Q1 108M $5.21B +$251M $48.23 328
2020 Q4 104M $5.59B +$117M $53.84 336
2020 Q3 102M $3.76B -$19.4M $36.89 290
2020 Q2 102M $3.17B +$258M $30.98 281
2020 Q1 94.2M $2.6B +$27.5M $27.61 268
2019 Q4 93.3M $2.73B +$45.2M $29.25 256
2019 Q3 87.1M $1.67B -$18.8M $19.12 249
2019 Q2 88M $1.93B +$198M $21.94 248
2019 Q1 80.3M $1.64B +$188M $20.46 235
2018 Q4 73.2M $923M -$107M $12.61 209
2018 Q3 78.2M $1.2B +$181M $15.35 165
2018 Q2 66.4M $870M -$6.69M $13.11 143
2018 Q1 67.1M $548M -$10.2M $8.16 135
2017 Q4 68.1M $604M +$5.68M $8.86 129
2017 Q3 64.9M $723M +$28M $11.13 134
2017 Q2 63.8M $572M +$44.9M $8.96 130
2017 Q1 61M $481M +$23M $7.89 140
2016 Q4 61.5M $527M +$18.9M $8.57 140
2016 Q3 59.9M $492M -$2.1M $8.22 133
2016 Q2 60.1M $483M +$27.7M $8.04 151
2016 Q1 56.6M $382M +$8.01M $6.74 119
2015 Q4 54.9M $432M +$134M $7.87 118
2015 Q3 38.4M $220M +$5.99M $5.73 98
2015 Q2 37.3M $202M +$12.9M $5.41 96
2015 Q1 34.1M $159M +$4.31M $4.67 82
2014 Q4 33.4M $139M -$2.65M $4.17 86
2014 Q3 33.6M $175M +$53M $5.21 86
2014 Q2 23.8M $79.1M +$507K $3.32 67
2014 Q1 23.8M $82.4M +$3.36M $3.47 69